Ultrasound-induced cascade nanozyme catalysis for enhanced tumor cell pyroptosis and systemic anti-tumor immunity
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. Enhancing cancer immunotherapy with nanomedicine10.1038/s41577-019-0269-6 ↗
2. Enhancing immunotherapy with tumour-responsive nanomaterials10.1038/s41571-025-01000-6 ↗
3. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches10.1038/s41392-025-02280-1 ↗
4. Immunotherapy augmentation through photothermal nanomaterial-mediated tumor microenvironment modulation10.1016/j.ccr.2025.217118 ↗
5. A pyroptosis nanotuner for cancer therapy10.1038/s41565-022-01125-0 ↗
6. Nanomedicine-Enabled/Augmented cell pyroptosis for efficient tumor nanotherapy10.1002/advs.202203583 ↗
7. A cooperative nano-CRISPR scaffold potentiates immunotherapy via activation of tumour-intrinsic pyroptosis10.1038/s41467-023-36550-9 ↗
8. The role of pyroptosis in modulating the tumor immune microenvironment10.1186/s40364-022-00391-3 ↗
9. Pyroptosis: shedding light on the mechanisms and links with cancers10.3389/fimmu.2023.1290885 ↗
10. Multienzyme-mimicking LaCoO3 nanotrigger for programming cancer-cell pyroptosis
11. Programmed targeting pyruvate metabolism therapy amplified single-atom nanozyme-activated pyroptosis for immunotherapy10.1002/adma.202312124 ↗
12. Ultrasmall iron-doped titanium oxide nanodots for enhanced sonodynamic and chemodynamic cancer therapy10.1021/acsnano.0c05235 ↗
13. Ultrasound-triggered and glycosylation inhibition-enhanced tumor piezocatalytic immunotherapy10.1038/s41467-024-53392-1 ↗
14. Fluorinated titanium Oxide (TiO2–xFx) nanospindles as ultrasound-triggered pyroptosis inducers to boost sonodynamic immunotherapy
15. Insights into the antibacterial mechanism of MoS2/CoS2 heterostructure nanozymes with double enzyme-like activities for MRSA-infected wound therapy10.1016/j.cej.2023.141959 ↗
16. Surface activation and Ni–S stabilization in NiO/NiS2 for efficient oxygen evolution reaction
17. Glucose oxidase-loaded MnFe2O4 nanoparticles for hyperthermia and cancer starvation therapy10.1021/acsanm.2c04960 ↗
18. One-step synthesis of Co-doped 1T-MoS2 nanosheets with efficient and stable HER activity in alkaline solutions10.1016/j.matchemphys.2020.122642 ↗
19. Cobalt-doping induced lattice distortion and 1T phase transition in MoS2 for boosted piezocatalytic methotrexate degradation10.1016/j.seppur.2025.134759 ↗
20. Photothermally reinforced nanozyme remodeling tumor microenvironment of redox and metabolic homeostasis to enhance ferroptosis in tumor therapy10.1021/acsnano.4c13087 ↗
21. Rational design of nanozymes for engineered cascade catalytic cancer therapy10.1021/acs.chemrev.4c00882 ↗
22. Protein-confined rotor strategy for quantum yield enhancement in supramolecular photosensitizers toward sentinel lymph node-targeted photodynamic immunoactivation10.1021/acsnano.5c04279 ↗
23. Ultrasmall metal alloy nanozymes mimicking neutrophil enzymatic cascades for tumor catalytic therapy10.1038/s41467-024-45668-3 ↗
24. A Dual-locked tandem fluorescent probe for imaging of pyroptosis in cancer chemo-immunotherapy
25. Intermetallics triggering pyroptosis and disulfidptosis in cancer cells promote anti-tumor immunity10.1038/s41467-024-53135-2 ↗
26. Defect-engineered sonopiezoelectric nanosheets enable sacrificial-agent-free hydrogen peroxide self-cycling for enhanced pancatalytic therapy10.1016/j.celbio.2025.100101 ↗
27. Pancatalytic medicine: a paradigm for non-toxic disease treatment10.1002/smll.202508415 ↗
28. A synergistic dual-atom sites nanozyme augments immunogenic cell death for efficient immunotherapy10.1002/advs.202414734 ↗
29. The gasdermin family: emerging therapeutic targets in diseases10.1038/s41392-024-01801-8 ↗
30. CXCR6 is required for antitumor efficacy of intratumoral CD8+ T cell10.1136/jitc-2021-003100 ↗